Getinge


 

THT 2023: Predictors for a Positive Hemodynamic & Clinical Response to Intra-aortic Counterpulsation

By Getinge FEATURING Reshad Garan
By Getinge FEATURING Reshad Garan
743 views
June 30, 2023

Welcome to the third presentation within the session, "THT 2023: MCS device selection in HF patients - Where does counterpulsation fit?", from the 2023 Technology and Heart Failure Therapeutics Conference.

The full-length session focuses on the unique physiological effects of counterpulsation in advanced heart failure patients. Moreover, the session provides guidance on MCS selection based on underlying etiology, clinical phenotyping, and predictors for positive hemodynamic and clinical response. Finally, you will be presented with novel applications for counterpulsation in HF.

To watch the full-length session, click here.

0 Comments
Login to view comments. Click here to Login
Heart Failure